Get the Stockscreener App
1.50
3.45%
0.05
After Hours:
1.43
-0.07
-4.67%
NanoViricides Inc stock is traded at $1.50, with a volume of 181.53K.
It is up +3.45% in the last 24 hours and down -23.08% over the past month.
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could provide functional cure for HIV/AIDS. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes virus infections; and eye drops against viral infections of the external eye, as well as involved in the other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
See More
Previous Close:
$1.45
Open:
$1.39
24h Volume:
181.53K
Relative Volume:
0.75
Market Cap:
$17.72M
Revenue:
-
Net Income/Loss:
$-9.36M
P/E Ratio:
-2.5424
EPS:
-0.59
Net Cash Flow:
$-6.20M
1W Performance:
-2.60%
1M Performance:
-23.08%
6M Performance:
+29.31%
1Y Performance:
+11.94%
1-Day Range:
$1.39
$1.51
1-Week Range:
$1.33
$1.59
52-Week Range:
$1.00
$3.59
NanoViricides Inc Stock (NNVC) Company Profile
Name
NanoViricides Inc
Sector
Industry
Phone
203-937-6137
Address
1 Controls Drive, Shelton, CT
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-15 | Initiated | Midtown Partners | Strong Buy |
NanoViricides Inc Stock (NNVC) Latest News
Oasis adds US, Canada and Mexico stops to 2025 tour - Oil City Derrick
NanoViricides prepares for Phase II trials for antiviral NV-387 - Proactive Investors USA
No arrests in South Africa mass shootings as death toll rises to 18 - Oil City Derrick
Over 90,000 Georgia residents sheltering a day after chemical plant fire sends chlorine into the air - Oil City Derrick
Rwanda reports 8 deaths linked to Ebola-like Marburg virus days after it declared an outbreak - Oil City Derrick
AT&T exits showbiz, sells remaining stake in DirecTV to private equity firm TPG for $7.6 billion - Oil City Derrick
NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical TrialMultiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID - News-Press Now
Vance criticized an infrastructure law as a candidate then embraced it as a senator - Oil City Derrick
NanoViricides, Inc. Reports Earnings Results for the Full Year Ended June 30, 2024 - Marketscreener.com
Orbán aide faces backlash for saying Hungary wouldn’t have fought a Russian invasion - Oil City Derrick
The number of Americans filing for jobless aid falls to lowest level in four months - Oil City Derrick
NanoViricides expands antiviral drug pipeline with TheraCour Pharma agreement - Proactive Investors USA
Brimma Tech Unveils Advanced AUS Sandbox Solution for Enhanced Mortgage Underwriting - Oil City Derrick
Harrods apologizes to women who say they were abused by former owner Mohamed Al Fayed - Oil City Derrick
China redoubles first-aid for its economy with support for banks and workers - Oil City Derrick
NanoViricides Executes an Agreement Encompassing All Antiviral Drug Treatments With Theracour, Including “Trojan Horse” Drugs - Oil City Derrick
NanoViricides Executes an Agreement Encompassing All Antiviral Drug Treatments With Theracour, Including “Trojan Horse” Drugs - StockTitan
Police are probing a cyberattack on Wi-Fi networks at UK train stations - Oil City Derrick
Taliban say it’s absurd to accuse them of gender discrimination - Oil City Derrick
Man who set off explosion at California courthouse had a criminal case there - Oil City Derrick
Japanese court acquits a former boxer in a 1966 murder retrial after decades on death row - Oil City Derrick
NASA, Boeing and Coast Guard representatives to testify about implosion of Titan submersible - Oil City Derrick
Hurricane Helene threatens 'unsurvivable' storm surge and vast inland damage, forecasters say - Oil City Derrick
Harris makes scandal-plagued Republican the star of her campaign to win North Carolina - Oil City Derrick
Judge dismisses lawsuit over mine sinkholes in South Dakota - Oil City Derrick
Tobra Medical Presenting Next Generation Tobra Bone Basket Autograft Collection System at 2024 North American Spine Conference (NASS) - Columbus Ledger-Enquirer
NanoViricides CEO talks lead drug asset’s potential as MPOX therapyICYMI - Proactive Investors USA
NanoViricides CEO talks lead drug asset’s potential as MPOX therapyICYMI - Proactive financial news
NanoViricides (NYSE:NNVC) Trading 3.1% Higher - Defense World
Healthcare Nanotechnology Market Innovations Investigated by Report, Size, Share, Growth, Trends, Competiti... - WhaTech Technology and Markets News
Nanomaterials Market Size In The New Analysis By Leading Research Firm - WhaTech
Nanomedicine Market Insights Discussed Regarding Demand, Growth Prediction, Segments And Outlook By 2033 - WhaTech
Nanoviricides Investigates NV-387 for MPOX Treatment Amid Global Outbreak - Proactive Investors
Financial Survey: XOMA (NASDAQ:XOMA) and NanoViricides (NYSE:NNVC) - Defense World
Mpox update – August 2024 - Marketscreener.com
NanoViricides exploring emergency protocol to evaluate NV-387 for MPOX - Proactive Investors USA
MPOX is Emerging as a Global ThreatNanoViricides Investigating MEURI Protocol for Using NV-387 to Treat MPOX - Oil City Derrick
MPOX is Emerging as a Global ThreatNanoViricides Investigating MEURI Protocol for Using NV-387 to Treat MPOX - StockTitan
Genital Herpes Research and Development Pipeline Market Generated Opportunities, Future Scope (2024-2034) - La Funcion mx
Quarterly Snapshot: Quick and Current Ratios for NanoViricides Inc (NNVC) - The Dwinnex
Check out these key findings about NanoViricides Inc (NNVC) - SETE News
NanoViricides Inc (AMEX:NNVC) stock crossing the finish line today - US Post News
NNVC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
NanoViricides prepares for Phase II trial of broad-spectrum antiviral NV-387 - Proactive Investors UK
NanoViricides Continues Its March Towards a Phase II Clinical Trial of NV-387A Potentially Revolutionary First Line Antiviral Therapy for RSV, COVID, and Other Viral Infections - Oil City Derrick
NanoViricides Continues Its March Towards a Phase II Clinical Trial of NV-387A Potentially Revolutionary First Line Antiviral Therapy for RSV, COVID, and Other Viral Infections - StockTitan
NanoViricides prepares for Phase II trial of broad-spectrum antiviral NV-387 - Proactive Investors USA
Siga stumbles in mpox study as Bavarian Nordic ramps up - BioWorld Online
NanoViricides extends executive contracts, grants stock By Investing.com - Investing.com Australia
NanoViricides extends executive contracts, grants stock By Investing.com - Investing.com Canada
NanoViricides extends executive contracts, grants stock - Investing.com
NanoViricides Inc Stock (NNVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):